Logo image of ESPR

ESPERION THERAPEUTICS INC (ESPR) Stock Analyst Ratings

NASDAQ:ESPR - Nasdaq - US29664W1053 - Common Stock - Currency: USD

0.87  -0.11 (-11.22%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to ESPR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.24. This target is 617.68% above the current price.
ESPR was analyzed by 14 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ESPR.
In the previous month the buy percentage consensus was at a similar level.
ESPR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
ESPR Historical Analyst RatingsESPR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 0.871.875.106.2416.80 - 114.77% 486.21% 617.68% 1,831.03%
ESPR Current Analyst RatingESPR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-05-07 Needham Maintains Buy -> Buy
2025-04-25 Needham Reiterate Buy -> Buy
2025-04-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-17 Goldman Sachs Maintains Neutral -> Neutral
2025-04-08 Needham Reiterate Buy -> Buy
2025-03-20 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-05 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-11 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-02-11 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-23 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-01-23 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-22 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-18 Goldman Sachs Reiterate Neutral
2024-12-17 Cantor Fitzgerald Initiate Overweight
2024-12-13 Needham Reiterate Buy -> Buy
2024-12-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-03 HC Wainwright & Co. Maintains Buy -> Buy
2024-12-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-27 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-13 Needham Maintains Buy -> Buy
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-28 Needham Reiterate Buy -> Buy
2024-06-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-20 B of A Securities Downgrade Neutral -> Underperform